ReviewBiomarker research2025

Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies.

Anamaria Bancos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.